Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome
European Journal of Cancer · 2024-05 · 202 · 114027
DOI: 10.1016/j.ejca.2024.114027 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Cancer, 2024-05. Verfasst von Stefano H Byer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, United States. Hauptthemen laut MEDLINE: Myocarditis, Myositis, Nitriles, Pyrazoles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, United States.
- Division of Cardiology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, United States.
- Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals, Iowa City, IA, United States. Electronic address: grewaludhayvir@gmail.com.
Zitieren
APA
Byer, S. H., Stewart, C., Mansour, S., & Grewal, U. S. (2024). Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome. European Journal of Cancer, 202, 114027. https://doi.org/10.1016/j.ejca.2024.114027
Vancouver
Byer SH, Stewart C, Mansour S, Grewal US. Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome. European Journal of Cancer. 2024;202:114027. doi:10.1016/j.ejca.2024.114027
BibTeX
@article{Byer2024,
author = {Byer, Stefano H and Stewart, Colten and Mansour, Shareef and Grewal, Udhayvir S},
title = {Novel use of abatacept and ruxolitinib as salvage therapy in steroid-refractory immune checkpoint blockade-induced myocarditis with myasthenia and myositis overlap syndrome},
journal = {European Journal of Cancer},
year = {2024},
volume = {202},
pages = {114027},
doi = {10.1016/j.ejca.2024.114027}
}
EUVIMED